1
|
Chou CW, Collopy AL, Kurz C, Lin Y, Harding ME, Plessow PN, Fortier T, Diddams S, Leibfried D, Leibrandt DR. Frequency-comb spectroscopy on pure quantum states of a single molecular ion. Science 2020; 367:1458-1461. [PMID: 32217722 PMCID: PMC10652508 DOI: 10.1126/science.aba3628] [Citation(s) in RCA: 26] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2019] [Accepted: 03/04/2020] [Indexed: 01/21/2023]
Abstract
Spectroscopy is a powerful tool for studying molecules and is commonly performed on large thermal molecular ensembles that are perturbed by motional shifts and interactions with the environment and one another, resulting in convoluted spectra and limited resolution. Here, we use quantum-logic techniques to prepare a trapped molecular ion in a single quantum state, drive terahertz rotational transitions with an optical frequency comb, and read out the final state nondestructively, leaving the molecule ready for further manipulation. We can resolve rotational transitions to 11 significant digits and derive the rotational constant of 40CaH+ to be B R = 142 501 777.9(1.7) kilohertz. Our approach is suited for a wide range of molecular ions, including polyatomics and species relevant for tests of fundamental physics, chemistry, and astrophysics.
Collapse
Affiliation(s)
- C W Chou
- Time and Frequency Division, National Institute of Standards and Technology, Boulder, CO 80305, USA.
| | - A L Collopy
- Time and Frequency Division, National Institute of Standards and Technology, Boulder, CO 80305, USA
| | - C Kurz
- Time and Frequency Division, National Institute of Standards and Technology, Boulder, CO 80305, USA
| | - Y Lin
- CAS Key Laboratory of Microscale Magnetic Resonance and Department of Modern Physics, University of Science and Technology of China, Hefei 230026, China
- Time and Frequency Division, National Institute of Standards and Technology, Boulder, CO 80305, USA
- Hefei National Laboratory for Physical Sciences at the Microscale, University of Science and Technology of China, Hefei 230026, China
- Synergetic Innovation Center of Quantum Information and Quantum Physics, University of Science and Technology of China, Hefei 230026, China
| | - M E Harding
- Institute of Nanotechnology, Karlsruhe Institute of Technology (KIT), 76021 Karlsruhe, Germany
| | - P N Plessow
- Institute of Catalysis Research and Technology, Karlsruhe Institute of Technology (KIT), 76021 Karlsruhe, Germany
| | - T Fortier
- Time and Frequency Division, National Institute of Standards and Technology, Boulder, CO 80305, USA
- Department of Physics, University of Colorado, Boulder, CO 80309, USA
| | - S Diddams
- Time and Frequency Division, National Institute of Standards and Technology, Boulder, CO 80305, USA
- Department of Physics, University of Colorado, Boulder, CO 80309, USA
| | - D Leibfried
- Time and Frequency Division, National Institute of Standards and Technology, Boulder, CO 80305, USA
- Department of Physics, University of Colorado, Boulder, CO 80309, USA
| | - D R Leibrandt
- Time and Frequency Division, National Institute of Standards and Technology, Boulder, CO 80305, USA
- Department of Physics, University of Colorado, Boulder, CO 80309, USA
| |
Collapse
|
2
|
Affiliation(s)
- F. Kaplan
- Institute of Nanotechnology, Karlsruhe Institute of Technology, Campus North, D-76344 Karlsruhe, Germany
| | - M. E. Harding
- Institute of Nanotechnology, Karlsruhe Institute of Technology, Campus North, D-76344 Karlsruhe, Germany
| | - C. Seiler
- Institute
of Theoretical Physics, University of Regensburg, D-93040 Regensburg, Germany
| | - F. Weigend
- Institute
of Theoretical Physics, University of Regensburg, D-93040 Regensburg, Germany
- Institute
of Physical Chemistry, Karlsruhe Institute of Technology, Campus
South, D-76021 Karlsruhe, Germany
| | - F. Evers
- Institute
of Theoretical Physics, University of Regensburg, D-93040 Regensburg, Germany
| | - M. J. van Setten
- Nanoscopic
Physics, Institute of Condensed Matter and Nanosciences, Université Catholique de Louvain, 1348 Louvain-la-Neuve, Belgium
| |
Collapse
|
3
|
Brady HR, Kamel KS, Harding ME, Cook GT, deVeber GA, Cardella CJ. Low dose ciclosporin from the early postoperative period yields potent immunosuppression after renal transplantation. Nephron Clin Pract 1990; 55:394-9. [PMID: 2202920 DOI: 10.1159/000186007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
Abstract
This study sought to determine if low doses of ciclosporin (CS) designed to give fasting serum levels of 50-100 ng/ml achieve effective immunosuppression when used from the early postoperative period after renal transplantation. Ninety-four primary renal transplant recipients were studied. Group 1 patients were treated with CS 100 ng/ml and prednisone (0.15 mg/kg/day). Group 2 patients received CS 50 ng/ml, prednisone (0.15 mg/kg/day) and azathioprine (1 mg/kg/day). These patients were compared to a control group of 26 patients (group 3) maintained on only prednisone and azathioprine. CS-treated patients suffered significantly fewer rejection episodes than control subjects (rejection episodes per patient in first year: group 1: 0.3 +/- SD 0.6; group 2: 0.7 +/- SD 0.7; group 3: 1.3 +/- SD 1.1, p less than 0.005). In addition, a greater number of CS-treated patients were completely free of rejection episodes during the first year posttransplant (group 1: 63%; group 2: 64%; group 3: 19%, p less than 0.005). Patient and graft survival were similar in all groups after 1 year (group 1: 92 and 92% respectively; group 2: 95 and 87% respectively; group 3: 96 and 85% respectively). These data suggest that the dose of CS required for effective immunosuppression in vivo is lower than has been previously thought.
Collapse
Affiliation(s)
- H R Brady
- Division of Nephrology, Toronto Western Hospital, University of Toronto, Ont., Canada
| | | | | | | | | | | |
Collapse
|
4
|
Cardella CJ, Harding ME, Abraham G, Robinson C, Oreopoulos D, Uldall PR, Jordan M, Cook G, Struthers N, Honey R. Renal transplantation in older patients on peritoneal dialysis. Transplant Proc 1989; 21:2022-3. [PMID: 2652660] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Affiliation(s)
- C J Cardella
- Division of Nephrology, University of Toronto, St. Michael's Hospital, Ontario, Canada
| | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Mendelssohn DC, Harding ME, Cardella CJ, Cook GT, Uldall PR. Management of end-stage autosomal dominant polycystic kidney disease with hemodialysis and transplantation. Clin Nephrol 1988; 30:315-9. [PMID: 3072137] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
Abstract
This is an analysis of the outcome of 35 patients with end-stage autosomal dominant polycystic kidney disease (ADPKD) at Toronto Western Hospital (TWH) during a 10-year period. The primary treatment in each case was hemodialysis. In the 15 patients managed exclusively with hemodialysis the one- and five-year actuarial survival was 93% and 77% respectively. Twenty patients ultimately received a total of 26 cadaveric renal allografts. Graft survival at one year was 76%. One- and five-year patient survival was 92% and 73% respectively. Beyond 5 years a trend towards increased survival in the transplant group was seen, compared with the exclusively hemodialyzed group. Bilateral nephrectomy prior to transplantation was associated with high morbidity and mortality, and did not change either graft or patient survival. In view of the similar survival and because it is accepted that transplantation offers the highest quality of life amongst the modalities of treatment for end-stage renal failure, transplantation should be considered the treatment of choice for end-stage ADPKD. There is no justification for routine bilateral nephrectomy before renal transplantation.
Collapse
|